New health plans cover treatments requiring two hours of hospitalisation, but exclusions remain critical.

India is enhancing its readiness for Ebola. The Union Health Ministry has directed states to boost surveillance and hospital preparedness. ...

A growing number of couples are choosing to delay parenthood in pursuit of career milestones, financial stability, and personal goals. But ...

The 2026 FIFA World Cup in North America faces a significant risk from soaring temperatures. Scientists warn that many matches could be pla...

The ET Women Conclave 2026 celebrated inspiring leaders, entrepreneurs, and changemakers with dialogues on authenticity, wellness, and impa...

The Guidance Document establishes, for the first time, a structured and standardised national framework for the screening, diagnosis, treat...

After the Gerald Ford Fire, the USS Higgins goes dark, and the US Navy's crisis deepens. A guided-missile destroyer loses all power and pro...

We are living in an era of extreme heat, and the planet is not pushing back on the pedal anytime soon. Which is why Lijee Philip brings to ...

India's dental tourism is experiencing significant growth. International patients are increasingly choosing India for advanced dental care,...

Defence Minister Rajnath Singh highlighted the need for clinical trial reforms in India. He suggested the Armed Forces Medical Services can...

The experts of the task force cited safety concerns and argued that Molnupiravir was not of much benefit in Covid treatment to arrive at th...

Experts are of the view that the clinicians can use it in their wisdom, but decided against recommending the drug in the national guideline...

A bench headed by Justice D Y Chandrachud was informed that there is a growing demand from some quarters to permit the use of Remdesivir ev...

The experts will also review evidence on anti-parasitic drug ivermectin. “The task force will review the overall Covid situation. Along wit...

The permission to market the drug was granted for the treatment of cytokine release syndrome in 'moderate' to 'severe' Acute Respiratory Di...

In a meeting held on July 14 to review the evidence, the task force headed by Niti Aayog member VK Paul decided against recommending the dr...

The updated protocol includes the advice to use dexamethasone as an alternative choice to methylprednisolone for managing moderate to sever...